Mojca Persic

1.8k total citations
12 papers, 345 citations indexed

About

Mojca Persic is a scholar working on Reproductive Medicine, Pulmonary and Respiratory Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Mojca Persic has authored 12 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Reproductive Medicine, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Obstetrics and Gynecology. Recurrent topics in Mojca Persic's work include Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Renal cell carcinoma treatment (3 papers). Mojca Persic is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Renal cell carcinoma treatment (3 papers). Mojca Persic collaborates with scholars based in United Kingdom, United States and Mexico. Mojca Persic's co-authors include Iain A. McNeish, Jonathan A. Ledermann, Helena Earl, Gordon Rustin, Allan Hackshaw, Timothy Perren, Gordon C. Jayson, Malcolm Adams, Martin Gore and Graham Temple and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and BJOG An International Journal of Obstetrics & Gynaecology.

In The Last Decade

Mojca Persic

12 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mojca Persic United Kingdom 6 167 147 103 93 70 12 345
Michaela Bártů Czechia 11 125 0.7× 112 0.8× 132 1.3× 36 0.4× 82 1.2× 52 385
Josep M. del Campo Spain 10 261 1.6× 187 1.3× 131 1.3× 89 1.0× 78 1.1× 20 439
Masataka Takenaka Japan 9 94 0.6× 96 0.7× 133 1.3× 42 0.5× 41 0.6× 22 342
Amy Guppy United Kingdom 6 112 0.7× 105 0.7× 80 0.8× 63 0.7× 38 0.5× 10 298
Toshiko Minamoto Japan 13 130 0.8× 262 1.8× 122 1.2× 205 2.2× 90 1.3× 34 538
J. Mazurka Canada 10 177 1.1× 120 0.8× 167 1.6× 68 0.7× 85 1.2× 15 488
Christopher DiSimone United States 6 133 0.8× 271 1.8× 114 1.1× 60 0.6× 148 2.1× 10 490
M. Lapresa Italy 10 294 1.8× 113 0.8× 69 0.7× 45 0.5× 42 0.6× 16 420
Cyril Abdeddaim France 10 173 1.0× 302 2.1× 77 0.7× 131 1.4× 92 1.3× 30 519
Kim McManus United States 9 134 0.8× 107 0.7× 120 1.2× 94 1.0× 69 1.0× 10 396

Countries citing papers authored by Mojca Persic

Since Specialization
Citations

This map shows the geographic impact of Mojca Persic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mojca Persic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mojca Persic more than expected).

Fields of papers citing papers by Mojca Persic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mojca Persic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mojca Persic. The network helps show where Mojca Persic may publish in the future.

Co-authorship network of co-authors of Mojca Persic

This figure shows the co-authorship network connecting the top 25 collaborators of Mojca Persic. A scholar is included among the top collaborators of Mojca Persic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mojca Persic. Mojca Persic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Eminowicz, Gemma, S. Vaja, David Gallardo, et al.. (2024). 710MO Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial. Annals of Oncology. 35. S545–S545. 1 indexed citations
2.
3.
4.
McCormack, Mary, Gemma Eminowicz, Patricia Díez, et al.. (2023). LBA8 A randomised phase III trial of induction chemotherapy followed by chemoradiation compared with chemoradiation alone in locally advanced cervical cancer: The GCIG INTERLACE trial. Annals of Oncology. 34. S1276–S1276. 35 indexed citations
5.
Watson, Lyn, et al.. (2021). Safety of hormone replacement therapy in women with a history of cervical adenocarcinoma. Post Reproductive Health. 27(3). 167–173. 12 indexed citations
6.
Ahmed, Irfan, Farook Al‐Azzawi, Joan Pitkin, et al.. (2021). Folic acid supplementation in postmenopausal women with hot flushes: phase III randomised double‐blind placebo‐controlled trial. BJOG An International Journal of Obstetrics & Gynaecology. 128(12). 2024–2033. 1 indexed citations
7.
Taibjee, Saleem, Simon O’Connor, Mojca Persic, et al.. (2015). Indolent CD8‐positive lymphoid proliferation of acral sites: three further cases of a rare entity and an update on a unique patient. Journal of Cutaneous Pathology. 43(2). 125–136. 31 indexed citations
8.
McNeish, Iain A., JA Ledermann, Lisa M. James, et al.. (2014). A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer. Annals of Oncology. 25(10). 1988–1995. 64 indexed citations
9.
Hall, Marcia, Ann Petruckevitch, Mojca Persic, et al.. (2014). Using Serum CA125 to Assess the Activity of Potential Cytostatic Agents in Ovarian Cancer. International Journal of Gynecological Cancer. 24(4). 676–681. 5 indexed citations
10.
McNeish, Iain A., Jonathan A. Ledermann, Lindsay E. James, et al.. (2013). A randomized placebo-controlled trial of saracatinib (AZD0530) plus weekly paclitaxel in platinum-resistant ovarian, fallopian-tube, or primary peritoneal cancer (SaPPrOC).. Journal of Clinical Oncology. 31(15_suppl). 5514–5514. 5 indexed citations
11.
Ledermann, Jonathan A., Allan Hackshaw, Gordon C. Jayson, et al.. (2011). Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer. Journal of Clinical Oncology. 29(28). 3798–3804. 164 indexed citations
12.
Rustin, Gordon, Nicholas Reed, Gordon C. Jayson, et al.. (2011). A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer. Annals of Oncology. 22(11). 2411–2416. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michaela Bártů Breakdown of academic impact, for papers by Josep M. del Campo Breakdown of academic impact, for papers by Masataka Takenaka Breakdown of academic impact, for papers by Amy Guppy Breakdown of academic impact, for papers by Toshiko Minamoto Breakdown of academic impact, for papers by J. Mazurka Breakdown of academic impact, for papers by Christopher DiSimone Breakdown of academic impact, for papers by M. Lapresa Breakdown of academic impact, for papers by Cyril Abdeddaim Breakdown of academic impact, for papers by Kim McManus
Rankless by CCL
2026